| Mr Michael T Nix, RPT | |
|
401 N Hayden St, Belzoni, MS 39038-3639 | |
| (662) 247-4446 | |
| (662) 247-2772 |
| Full Name | Mr Michael T Nix |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 20 Years |
| Location | 401 N Hayden St, Belzoni, Mississippi |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932196912 | NPI | - | NPPES |
| 01873070 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT3777 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Rehabilitation, Llc | 9931194693 | 5 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for the use of luliconazole, its lead product candidate, in patients with onychomycosis (nail and nail bed fungal infections).
Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient water-based system for the synthesis of organic compounds typically used in pharmaceuticals, agrochemicals, cosmetics, plastics, textiles and household chemicals.
Artificial camouflage that imitates concealment technologies existing in the natural world, such as the ones found in chameleon and octopus, is recently attracting a great attention for various military applications in the forms of wearable devices and soft robots.
› Verified 4 days ago
| Provider Name | Advanced Rehabilitation, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164419222 PECOS PAC ID: 9931194693 Enrollment ID: O20040420000965 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for the use of luliconazole, its lead product candidate, in patients with onychomycosis (nail and nail bed fungal infections).
Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient water-based system for the synthesis of organic compounds typically used in pharmaceuticals, agrochemicals, cosmetics, plastics, textiles and household chemicals.
Artificial camouflage that imitates concealment technologies existing in the natural world, such as the ones found in chameleon and octopus, is recently attracting a great attention for various military applications in the forms of wearable devices and soft robots.
› Verified 4 days ago
| Provider Name | Professional Physical Therapy, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720282247 PECOS PAC ID: 2466442389 Enrollment ID: O20040513000906 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for the use of luliconazole, its lead product candidate, in patients with onychomycosis (nail and nail bed fungal infections).
Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient water-based system for the synthesis of organic compounds typically used in pharmaceuticals, agrochemicals, cosmetics, plastics, textiles and household chemicals.
Artificial camouflage that imitates concealment technologies existing in the natural world, such as the ones found in chameleon and octopus, is recently attracting a great attention for various military applications in the forms of wearable devices and soft robots.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael T Nix, RPT 401 N Hayden St, Belzoni, MS 39038-3639 Ph: (662) 247-4446 | Mr Michael T Nix, RPT 401 N Hayden St, Belzoni, MS 39038-3639 Ph: (662) 247-4446 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for the use of luliconazole, its lead product candidate, in patients with onychomycosis (nail and nail bed fungal infections).
Chemists at The University of Texas at Arlington have devised a safer, more environmentally friendly, less expensive and more efficient water-based system for the synthesis of organic compounds typically used in pharmaceuticals, agrochemicals, cosmetics, plastics, textiles and household chemicals.
Artificial camouflage that imitates concealment technologies existing in the natural world, such as the ones found in chameleon and octopus, is recently attracting a great attention for various military applications in the forms of wearable devices and soft robots.
› Verified 4 days ago
Katherine Flautt, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 401 N Hayden St, Belzoni, MS 39038 Phone: 662-247-4446 Fax: 662-247-2772 | |
Mr. Bryant W. Lary, R.P.T. Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 401 N Hayden St, Belzoni, MS 39038 Phone: 662-247-4446 Fax: 662-247-2772 | |
Mabry Lynne Bailey, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 Penn St, Belzoni, MS 39038 Phone: 662-820-1289 | |
Professional Physical Therapy, Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 401 N Hayden St, Belzoni, MS 39038 Phone: 662-247-4446 Fax: 662-247-2772 |